Corporate Banner
Satellite Banner
qPCR
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Biogazelle Serves as Reference Laboratory for Bio-Rad's ddPCR System

Published: Monday, September 30, 2013
Last Updated: Monday, September 30, 2013
Bookmark and Share
Biogazelle’s and Bio-Rad’s long-term partnership extends.

Biogazelle has announced that it is serving a reference laboratory for Bio-Rad’s QX200™ Digital Droplet PCR™ system (ddPCR) in Europe. This extends Biogazelle’s and Bio-Rad’s long-term partnership for PCR-based solutions.

As a reference laboratory, Biogazelle uses ddPCR in its R&D programs and shares its ddPCR user experience with the PCR community.

In addition, Biogazelle is acting as a ddPCR service provider for third parties who are interested in outsourcing a study. In addition, the Biogazelle laboratory also serves as a live research environment for prospective QX200 system customers.

Professor Jo Vandesompele, co-founder of Biogazelle, welcomes the agreement: "We are a young and dynamic company, eager to learn from and to teach the PCR research community. Being a reference center for ddPCR is completely in line with our mission to address unmet needs through excellence in science and technology."

Digital PCR is a nucleic acid quantification method with unprecedented resolution and relative sensitivity. It can determine how many nucleic acid target molecules are present in a particular sample by counting how many miniaturized reactions are positive if the template is partitioned into 1000’s of parallel reactions.

The QX200 system uses droplets as partitions to perform ddPCR. It is a flexible and high throughput instrument with an optimal number of partitions per sample. Both probe and dye based assays can be used.

Biogazelle is at the forefront of digital PCR-based research, as it was one of the first European laboratories that had access to the technology in 2012. The co-founders are also co-author on the digital MIQE guidelines (Huggett et al., Clinical Chemistry, 2013).

Biogazelle is working on various ddPCR projects, including (i) gene copy number quantification to determine the stability of transgenic cells or organisms, (ii) splice variant quantification, (iii) quantification of pathogenic organisms, and (iv) rare event detection for cancer diagnostics and monitoring of patient response to treatment.

By sharing its expertise in assay development, experiment design and nucleic acid quantification, Biogazelle aims to serve the digital PCR community. In addition, Biogazelle will use its experience to provide digital PCR services for academic and industrial customers.

Dr. Jan Hellemans, co-founder of Biogazelle, acknowledges the great potential digital PCR holds for clinical diagnostics. "Data interpretation is quite straightforward and results can easily be shared and interpreted among different users because absolute concentrations are determined. Moreover, its inherently high precision, accuracy and relative sensitivity are relevant features for laboratory tests that are used in the clinic. Biogazelle is proud to accelerate ddPCR discoveries, bringing ddPCR closer to the clinic."


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Biogazelle Attracts New Investors
UGent spin-off Biogazelle attracts new investors QBIC Arkiv Fund, Foundation Majoie and SOFI to finance growth.
Tuesday, October 07, 2014
VIB Inks qBase+ Group Licensing Agreement with Biogazelle
VIB to accelerate its qPCR analyses by using qbase+ as the software.
Monday, May 20, 2013
Biogazelle Appoints Kris Vanhercke as Chief Operating Officer
New appointment strengthens business development and marketing expertise of Biogazelle.
Monday, September 24, 2012
Scientific News
Ultrafast DNA Diagnostics
New technology developed by UC Berkeley bioengineers promises to make a workhorse lab tool cheaper, more portable and many times faster by accelerating the heating and cooling of genetic samples with the switch of a light.
The Genetic Roots of Adolescent Scoliosis
Scientists at the RIKEN Center for Integrative Medical Sciences in collaboration with Keio University in Japan have discovered a gene that is linked to susceptibility of Scoliosis.
Diagnostic Test Developed for Enterovirus D68
researchers at Washington University School of Medicine in St. Louis have developed a diagnostic test to quickly detect enterovirus D68 (EV-D68), a respiratory virus that caused unusually severe illness in children last year.
Simple Technology Makes CRISPR Gene Editing Cheaper
University of California, Berkeley, researchers have discovered a much cheaper and easier way to target a hot new gene editing tool, CRISPR-Cas9, to cut or label DNA.
RNAi Screening Trends
Understand current trends and learn which application areas are expected to gain in popularity over the next few years.
HPV Genomes Show Greater Diversity Than Expected in Cancer Patients
The findings could have implications for eventually understanding why some cervical lesions become malignant.
Rapidly Detecting Drug-Resistant HepC
A nested PCR-based assay has been shown to rapidly and accurately detect drug-resistant strains of the hepatitis C virus.
Researchers Seek Water Test for Invasive Species Detection
Detecting invasive lake and river species using just a water sample would be a dream come true for wildlife managers and regulators in the state and University of Maine researchers may soon make this an inexpensive reality.
New Cell Structure Finding Might Lead to Novel Cancer Therapies
University of Warwick scientists in the U.K. say they have discovered a cell structure which could help researchers understand why some cancers develop.
Ebola Assays Compared in Head-to-Head Analysis
A newly published study has attempted to rigorously evaluate a few of the assays recently granted Emergency Use Authorization by the US Food and Drug Administration to test for Ebola Zaire virus.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!